Nuxia sphaerocephala

Traditional preparations of Nuxia sphaerocephala are documented as infusions, decoctions, and macerations across parts of East and southern Africa. In Madagascar, local practitioners prepare an infusion of the leaves for coughs and colds, and a bark decoction for stomach complaints and worms; these uses are noted in the Flore de Madagascar et des Comores (Dubard, 1906). Among the Makhuwa of northern Mozambique, the leaves are infused to alleviate abdominal pain and fever, while root infusions are taken as a bitter tonic (Koechlin, 1960). In Malawi and Zambia, healers decoct the bark or whole stems to treat stomachache, dysentery, and intestinal parasites; leaf infusions are also drunk as a general tonic during fevers (Watt & Breyer-Brandwijk, 1962; White, 1962). Elsewhere in East Africa and Madagascar, macerated stems and bark have been applied topically in poultices to treat wounds and ulcers, and as a wash for skin infections (Brenan, 1963; Miller, 1996).

For practical use, a typical mild tea can be made by steeping 1–2 teaspoons (about 2–4 g) of dried leaf in 250 mL of freshly boiled water for 5–10 minutes; strain and drink 1 cup two to three times daily. For a tincture, a 1:5 w:v extract by macerating 100 g of dried bark in 500 mL of 45% ethanol for four weeks in a cool, dark place, shaking daily, is common in herbal texts of the region. Safety guidance is conservative: people with liver disease should avoid bitter-tonic or anthelmintic preparations; data in pregnancy and lactation are limited, and caution is advised. Children should receive lower doses, and any preparation causing persistent digestive upset should be discontinued (Dubard, 1906; Watt & Breyer-Brandwijk, 1962; Miller, 1996).

The bitterness and gastrointestinal activity of Nuxia sphaerocephala can be linked to several well-established constituents. Bark and roots contain phenylethanoid glycosides such as verbascoside and forsythoside B, reported for Nuxia species and likely responsible for antimicrobial and anti-inflammatory effects. Anthraquinones (e.g., chrysophanol) have been identified in the genus and may support traditional anthelmintic uses (Svoboda, 1990; Grenand et al., 2004). Iridoid monoterpenes (e.g., aucubin and harpagide) are present in Buddlejoideae, including Nuxia, and offer a plausible basis for the observed spasmolytic and antispasmodic actions traditionally associated with abdominal pain (Miller, 1996).

While phytochemical research and regional ethnobotanical interest continue, Nuxia sphaerocephala remains primarily a regional remedy. Commercial products are uncommon outside local markets and traditional dispensaries, but dried leaf teas and bark tinctures can occasionally be found in herb shops in Madagascar and parts of East Africa, reflecting enduring local practice (Koechlin, 1960; Miller, 1996).

No general uses added yet. Help us by writing one.

No common names added yet.

No subspecies added yet.

No variety added yet.

No subvariety added yet.

No forms added yet.

No germination or propagation data was added yet.

No reference genome is available on NCBI yet. We are constantly monitoring for new data.

No known contributors. Be the first!

In private collections	0
In public collections	0

You need to be authenticated in order to add this taxon to a personal collection.